Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Presurgical phase II study of metformin on breast cancer cell proliferation
ISRCTN16493703Phase 2Completed
- Sponsor
- European Institute of Oncology
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing Metformin with Placebo (2 arms). Primary endpoints: Short-term response in Ki-67 labeling index and Percent change in Ki-67 labeling index. Started Dec 2008; status: completed.
02
Drugs
metformin
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN16493703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16493703.